Table 2. Association between serum resistin levels and CAD occurrence in case-control studies.
GHS-cross sectional design | JHS | |||
CAD Negative n = 416 | CAD Positive n = 360 | CAD Negative n = 443 | CAD Positive n = 418 | |
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Model 1 | 1.29 (1.10–1.51) | 0.002 | 1.83 (1.49–2.24) | 3.53×10−12 |
Model 2 | 1.35 (1.10–1.64) | 0.002 | 1.99 (1.55–2.55) | 2.95×10−13 |
Model 3 | 1.10 (0.93–1.30) | 0.260 | N.A. | N.A. |
GHS: Gargano Heart Study; JHS: Joslin Heart Study; CAD: Coronary Artery Disease.
OR (95% CI) are given for SD increase of resistin levels.
Model 1: unadjusted.
Model 2: adjusted for age, sex, smoking habits, BMI, HbA1c, insulin therapy, hypertension and dyslipidemia.
Model 3: adjusted for plasma fibrinogen.
N.A: Not Available.